November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 01, 2025
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, due to which stem cells are being continuously grown and studied to treat various cancers....
November 01, 2025
The preparative and process chromatography market size is calculated at $12.39 bn in 2025 is to hit $27.16 bn by 2034. The market is evolving with innovations like Gilson's VERITY LC system for drug discovery and Tecan's Resolvex Prep for efficient sample prep. Shimadzu's strong Q1 2024 sales of 116,938M yen reflect its expertise in analytical inst...
November 01, 2025
The personalized retail nutrition and wellness market size is calculated at $4.54 bn in 2025 is to hit $16.25 bn by 2034. In recent months, telenutrition and food-as-medicine startups have made strides. Nourish raised $35M to expand its platform and RD network, Verdify secured €2.4M to grow personalized nutrition solutions, and Heali launched ...
November 01, 2025
The research grade proteins market size is calculated at $1.31 bn in 2025 is to hit $4.81 bn by 2034. In 2024, Sanofi invested €40M in its Lyon Gerland site, focusing €25M on Thymoglobulin production. Allozymes raised $15M to expand in Europe. IISc pioneered a safer protein synthesis method using MSG. Spear Bio secured $45M for qPCR advan...
November 01, 2025
The dental equipment market size is calculated at $12.71 bn in 2025 is to hit $22.1 bn by 2034. In 2024, key dental market updates include Tallahassee State College’s $1M dental lab launch, India upgrading its Government Dental College with advanced tech, and Midwest Dental partnering with Pearl to integrate AI solutions like Second Opinion a...
November 01, 2025
The automated and closed cell therapy processing systems market size is calculated at $1.74 bn in 2025 is to hit $8.86 bn by 2034. The automated and closed cell therapy market sees key advancements: Cellular Origins partnered with Fresenius Kabi (Oct 2024) for robotic manufacturing; Multiply Labs collaborated with Stanford Medicine (Apr 2024) on au...
November 01, 2025
The food allergy treatment market size is calculated at $7.47 bn in 2025 is to hit $15.32 bn by 2034. In 2024, notable advancements in food allergy treatment include Mitsubishi Gas Chemical's partnership with Alerje to enhance global allergy care, the U.S. FDA's approval of Xolair for severe allergies, and Inimmune's collaboration with Intrommune t...
November 01, 2025
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. Duke Children’s Hospital launched a trial on new anti-rejection medications in children. Astel...
November 01, 2025
The cholera vaccines market size is calculated at $103.99 mn in 2025 is to hit $246 mn by 2034. In early 2025, Nakonde, Zambia, launched a cholera vaccination campaign targeting 191,153 people. In October 2024, India’s ICMR and NIRBD began a pilot project to vaccinate 50,000 individuals with Euvichol-Plus. In March 2024, IVI initiated a tech ...
November 01, 2025
The enzyme replacement therapy market size is calculated at $11.34 bn in 2025 is to hit $24.71 bn by 2034. In January 2025, Denali Therapeutics received FDA Breakthrough Therapy Designation for DNL310 (tividenofusp alfa) for Hunter syndrome. In July 2024, GC Biopharma’s GC1130A got fast-track status for Sanfilippo syndrome type A. In December...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com